Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04352868

Customizing Myopia Control With Multifocal Toric Contact Lens

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
8 Years – 12 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the ability of toric multifocal contact lens to reduce the change of myopia progression in children (aged 8-12) with myopic astigmatism.

Detailed description

The purpose of this study is to assess if a center distance toric multifocal contact lenses can slow the amount of change of myopia progression in children with myopia plus astigmatism. Multifocal contact lenses have been theorized to influence the peripheral optics of the eye such that they slow the rate of myopia progression in nearsighted children. This outcome is yet to be evaluated in children with myopia plus astigmatism.The secondary outcome is to measure the change in peripheral optics caused by the contact lens. This information is key to understanding the mechanism of multifocal contact lens optics on the eye. Ultimately this information would be used to create a software that can estimate the effect of multifocal contact lenses on the peripheral optics of the child's eye. This software can potentially be used by practitioners worldwide to better customize multifocal contact lenses to slow myopia progression.

Conditions

Interventions

TypeNameDescription
DEVICEIntelliwave multifocal, toric, soft contact lensThis is a quarterly disposable, multifocal, toric soft contact lens commercially available from Art Optical Contact Lens, Inc.
DEVICEIntelliwave toric, soft contact lensThis is a quarterly disposable toric soft contact lens commercially available from Art Optical Contact Lens, Inc.

Timeline

Start date
2020-09-01
Primary completion
2021-09-01
Completion
2022-09-01
First posted
2020-04-20
Last updated
2020-11-09

Regulatory

Source: ClinicalTrials.gov record NCT04352868. Inclusion in this directory is not an endorsement.